692 related articles for article (PubMed ID: 24074795)
1. Extracellular matrix components in breast cancer progression and metastasis.
Oskarsson T
Breast; 2013 Aug; 22 Suppl 2():S66-72. PubMed ID: 24074795
[TBL] [Abstract][Full Text] [Related]
2. The extracellular matrix in breast cancer.
Insua-Rodríguez J; Oskarsson T
Adv Drug Deliv Rev; 2016 Feb; 97():41-55. PubMed ID: 26743193
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs target the pro-tumorigenic extracellular matrix of the postpartum mammary gland.
O'Brien J; Hansen K; Barkan D; Green J; Schedin P; O'Brien J; Hansen K; Barkan D; Green J; Schedin P
Int J Dev Biol; 2011; 55(7-9):745-55. PubMed ID: 22161831
[TBL] [Abstract][Full Text] [Related]
4. The niche under siege: novel targets for metastasis therapy.
Santamaria-Martínez A; Huelsken J
J Intern Med; 2013 Aug; 274(2):127-36. PubMed ID: 23253195
[TBL] [Abstract][Full Text] [Related]
5. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion.
Bemis LT; Schedin P
Cancer Res; 2000 Jul; 60(13):3414-8. PubMed ID: 10910049
[TBL] [Abstract][Full Text] [Related]
6. Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis.
McDaniel SM; Rumer KK; Biroc SL; Metz RP; Singh M; Porter W; Schedin P
Am J Pathol; 2006 Feb; 168(2):608-20. PubMed ID: 16436674
[TBL] [Abstract][Full Text] [Related]
7. Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments.
Goddard ET; Hill RC; Barrett A; Betts C; Guo Q; Maller O; Borges VF; Hansen KC; Schedin P
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):223-232. PubMed ID: 27771439
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
[TBL] [Abstract][Full Text] [Related]
9. Significance of stromal decorin expression during the progression of breast cancer.
Oda G; Sato T; Ishikawa T; Kawachi H; Nakagawa T; Kuwayama T; Ishiguro M; Iida S; Uetake H; Sugihara K
Oncol Rep; 2012 Dec; 28(6):2003-8. PubMed ID: 22992875
[TBL] [Abstract][Full Text] [Related]
10. Mammary ECM composition and function are altered by reproductive state.
Schedin P; Mitrenga T; McDaniel S; Kaeck M
Mol Carcinog; 2004 Dec; 41(4):207-20. PubMed ID: 15468292
[TBL] [Abstract][Full Text] [Related]
11. The molecular composition of the metastatic niche.
Descot A; Oskarsson T
Exp Cell Res; 2013 Jul; 319(11):1679-86. PubMed ID: 23707205
[TBL] [Abstract][Full Text] [Related]
12. Interaction between extracellular cancer matrix and stromal breast cells.
Gehmert S; Lehoczky G; Loibl M; Jung F; Prantl L; Gehmert S
Clin Hemorheol Microcirc; 2020; 74(1):45-52. PubMed ID: 31796667
[TBL] [Abstract][Full Text] [Related]
13. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
14. Integrated extracellular matrix signaling in mammary gland development and breast cancer progression.
Zhu J; Xiong G; Trinkle C; Xu R
Histol Histopathol; 2014 Sep; 29(9):1083-92. PubMed ID: 24682974
[TBL] [Abstract][Full Text] [Related]
15. A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.
Stein T; Salomonis N; Nuyten DS; van de Vijver MJ; Gusterson BA
J Mammary Gland Biol Neoplasia; 2009 Jun; 14(2):99-116. PubMed ID: 19408105
[TBL] [Abstract][Full Text] [Related]
16. Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects.
Urooj T; Wasim B; Mushtaq S; Shah SNN; Shah M
Curr Cancer Drug Targets; 2020; 20(3):168-186. PubMed ID: 31858911
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix.
Davison CA; Durbin SM; Thau MR; Zellmer VR; Chapman SE; Diener J; Wathen C; Leevy WM; Schafer ZT
Cancer Res; 2013 Jun; 73(12):3704-15. PubMed ID: 23771908
[TBL] [Abstract][Full Text] [Related]
18. Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.
Oudin MJ; Jonas O; Kosciuk T; Broye LC; Guido BC; Wyckoff J; Riquelme D; Lamar JM; Asokan SB; Whittaker C; Ma D; Langer R; Cima MJ; Wisinski KB; Hynes RO; Lauffenburger DA; Keely PJ; Bear JE; Gertler FB
Cancer Discov; 2016 May; 6(5):516-31. PubMed ID: 26811325
[TBL] [Abstract][Full Text] [Related]
19. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
Eckhardt BL; Parker BS; van Laar RK; Restall CM; Natoli AL; Tavaria MD; Stanley KL; Sloan EK; Moseley JM; Anderson RL
Mol Cancer Res; 2005 Jan; 3(1):1-13. PubMed ID: 15671244
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype.
Valdés-Mora F; Salomon R; Gloss BS; Law AMK; Venhuizen J; Castillo L; Murphy KJ; Magenau A; Papanicolaou M; Rodriguez de la Fuente L; Roden DL; Colino-Sanguino Y; Kikhtyak Z; Farbehi N; Conway JRW; Sikta N; Oakes SR; Cox TR; O'Donoghue SI; Timpson P; Ormandy CJ; Gallego-Ortega D
Cell Rep; 2021 Apr; 35(2):108945. PubMed ID: 33852842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
